BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Farrugia A, Liumbruno GM, Candura F, Profili S, Cassar J. Factors affecting the quality, safety and marketing approval of clotting factor concentrates for haemophilia. Blood Transfus 2018;16:525-34. [PMID: 30201084 DOI: 10.2450/2018.0150-18] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Hay CRM, Nissen F, Pipe SW. Mortality in congenital hemophilia A - a systematic literature review. J Thromb Haemost 2021;19 Suppl 1:6-20. [PMID: 33331043 DOI: 10.1111/jth.15189] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
2 Franchini M, Marano G, Pati I, Candura F, Profili S, Veropalumbo E, Masiello F, Catalano L, Piccinini V, Vaglio S, Pupella S, Liumbruno GM. Emicizumab for the treatment of haemophilia A: a narrative review. Blood Transfus 2019;17:223-8. [PMID: 31246563 DOI: 10.2450/2019.0026-19] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
3 Massimo Franchini, Giancarlo M. Liumbruno. “The times they are a-changin”, ... or maybe not? Blood Transfus 2019;17. [PMID: 31846604 DOI: 10.2450/2019.0259-19] [Reference Citation Analysis]
4 Zanon E, Pasca S. Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years. Blood Transfus 2019;17:378-84. [PMID: 30747705 DOI: 10.2450/2019.0253-18] [Cited by in F6Publishing: 10] [Reference Citation Analysis]